AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2012
Feb 6, 2012
34301_dirs_2012-02-06_5b5d6f5f-6bb7-4f4c-aeab-fe6305ea93ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-02-02
Reporting Person: CALHOUN CHRISTOPHER J (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-02 | Common Stock | M | 182150 | $3.09 | Acquired | 350525 | Direct |
| 2012-02-02 | Common Stock | S | 40400 | $4.00 | Disposed | 310125 | Direct |
| 2012-02-02 | Common Stock | S | 68750 | $4.01 | Disposed | 241375 | Direct |
| 2012-02-02 | Common Stock | S | 35400 | $4.02 | Disposed | 205975 | Direct |
| 2012-02-02 | Common Stock | S | 5337 | $4.03 | Disposed | 200638 | Direct |
| 2012-02-02 | Common Stock | S | 7463 | $4.04 | Disposed | 193175 | Direct |
| 2012-02-02 | Common Stock | S | 5183 | $4.05 | Disposed | 187992 | Direct |
| 2012-02-02 | Common Stock | S | 7595 | $4.06 | Disposed | 180397 | Direct |
| 2012-02-02 | Common Stock | S | 4305 | $4.07 | Disposed | 176092 | Direct |
| 2012-02-02 | Common Stock | S | 617 | $4.08 | Disposed | 175475 | Direct |
| 2012-02-02 | Common Stock | S | 2100 | $4.09 | Disposed | 173375 | Direct |
| 2012-02-02 | Common Stock | S | 3300 | $4.10 | Disposed | 170075 | Direct |
| 2012-02-02 | Common Stock | S | 1700 | $4.11 | Disposed | 168375 | Direct |
| 2012-02-03 | Common Stock | M | 22850 | $3.09 | Acquired | 191225 | Direct |
| 2012-02-03 | Common Stock | S | 5388 | $4.00 | Disposed | 185837 | Direct |
| 2012-02-03 | Common Stock | S | 5400 | $4.01 | Disposed | 180437 | Direct |
| 2012-02-03 | Common Stock | S | 400 | $4.02 | Disposed | 180037 | Direct |
| 2012-02-03 | Common Stock | S | 600 | $4.03 | Disposed | 179437 | Direct |
| 2012-02-03 | Common Stock | S | 100 | $4.04 | Disposed | 179337 | Direct |
| 2012-02-03 | Common Stock | S | 1600 | $4.05 | Disposed | 177737 | Direct |
| 2012-02-03 | Common Stock | S | 1112 | $4.06 | Disposed | 176625 | Direct |
| 2012-02-03 | Common Stock | S | 3500 | $4.07 | Disposed | 173125 | Direct |
| 2012-02-03 | Common Stock | S | 4650 | $4.08 | Disposed | 168475 | Direct |
| 2012-02-03 | Common Stock | S | 100 | $4.10 | Disposed | 168375 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-02 | Employee Stock Option | $3.09 | M | 182150 | Disposed | 2012-02-08 | Common Stock (182150) | Direct |
| 2012-02-03 | Employee Stock Option | $3.09 | M | 22850 | Disposed | 2012-02-08 | Common Stock (22850) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 36850 | Indirect |
Footnotes
F1: Shares sold pursuant to a 10b5-1 Plan.
F2: These stock options would have expired 02/08/2012 if not exercised and Company will receive $633,450 in total proceeds from the exercises.
F3: The Employee Stock options vested monthly from the grant date (02/08/2002) at a rate of 1/48th each month thereafter.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26